Possibility Related Posts:
- Promote research against rare diseases
On February 19, 2010, players of the platform Rare Diseases recalled that government intervention should always be accrue1. This must be a real chal... - Homeopathy
What is and what homeopathy cure
Homeopathy is a so-called alternative medicines, possibly the best known worldwide.
Homeopathy is based on two ... - Vitamin D “solar” is a key health
Vitamin D is vital to activate human defenses and poor who suffer nearly half the world population could mean that T cells that attack the immune syst... - What is a chronic disease?
Experts define chronic disease as those whose long term purpose or cure can not be clearly predicted or will never happen.
Although there is no con... - Colds, Flu How to differentiate?
Autumn and winter are seasons that are conducive to suffer colds or colds and flu. Both processes are infections, while sharing certain characteristic...
The high burden of care which currently offers osteoporosis, with over 200 million sufferers worldwide, about 2 million in Spain, “after the high functional impact fractures, since 50% of patients lose their independence, and increased average life expectancy of the population, which has led to an expansion of the geriatric population, a sector where osteoporosis is primed, clearly indicate that this is going to be rheumatic disease throughout this century one of the diseases with the highest relevance.
Moreover, this life expectancy is increasing in developing countries, so that osteoporosis, a disease important only in developed countries, will become a global epidemic. Osteoporosis causes 1.6 million hip fractures worldwide each year, 40,000 of which occur in our country, and this was also associated with a significant increase in mortality.
In particular, there is an increased relative risk of death by 86%. That is, if older than 65 years, the risk of dying within 5 years is 20%, a person with hip fracture have a 86% increased risk, equivalent to approximately 37% will die.
Given the importance of this condition and the need for advanced knowledge as possible by specialists to reduce these figures just presented the second edition of ‘Bone Diseases Manual’ of the Spanish Society of Rheumatology . The work was coordinated by Dr. Luis Pérez Edo, Rheumatology Service, Hospital del Mar in Barcelona, and Dr. Luis Arboleya, Rheumatology Service, Hospital San Agustin, Avilés. (more…)